SS&C Technologies Holdings Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SS&C Technologies Holdings Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,481	1,675	3,421	4,633	4,668	5,051	5,283	5,503	5,882	6,272
Cost of revenue	801	886	2,051	2,612	2,574	2,642	2,768	2,851	3,018	3,251
Gross profit	681	789	1,370	2,021	2,094	2,409	2,515	2,652	2,864	3,022
Research and development	153	153	318	384	399	415	447	474	518	508
Selling and marketing	117	119	211	354	356	394	500	551	584	625
General and administrative	123	120	314	369	352	358	425	418	418	452
Operating expenses	392	392	941	1,107	1,108	1,167	1,372	1,443	1,520	1,585
Operating income	289	397	429	914	986	1,242	1,143	1,209	1,344	1,437
Interest expense	130	109	280	410	250	206	312	476	463	435
Other non-operating income	3.4	-4.5	8.2	25.7	41.6	18.2	20.8	20.7	8.9	-23
Pre-tax income	164	283	125	532	776	1,037	876	858	894	975
Income tax	32.6	-46.2	21.9	93.2	151	236	227	249	132	176
Net income to minority interests					0	0.6	-1.2	1.5	1.2	1.8
Net income	131	329	103	439	625	800	650	607	761	797
EBITDA	517	634	948	1,690	1,711	1,910	1,815	1,879	2,024	2,141
EPS, basic	0.65	1.60	0.44	1.73	2.44	3.13	2.56	2.45	3.09	3.26
EPS, diluted	0.64	1.55	0.42	1.66	2.35	2.99	2.48	2.39	3.00	3.15
Shares, basic (weighted)	200	205	233	253	256	256	254	248	246	244
Shares, diluted (weighted)	206	212	244	264	267	267	262	255	254	253
Dividend per share	0.25	0.27	0.30	0.43	0.53	0.68	0.80	0.88	0.98	1.04

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	118	64.1	167	153	209	564	440	432	567	462
Receivables	241	244	682	670	648	713	779	799	902	979
Other current assets	31.1	38.7	160	205	188	188	194	166	180	194
Total current assets	415	359	2,048	2,786	2,299	4,252	2,424	4,052	4,862	5,488
Property, plant and equipment	80.4	101	553	466	413	382	344	315	300	290
Lease right-of-use assets				375	351	291	261	221	191	233
Goodwill	3,653	3,708	7,858	7,960	8,079	8,046	8,863	8,970	9,218	9,991
Intangible assets	1,533	1,342	4,961	4,397	3,902	3,407	3,707	3,256	3,131	3,238
Long-term investments		0	191	160	184	173	194	185	177	174
Total assets	5,707	5,540	16,108	16,741	15,924	17,333	16,653	18,103	19,045	20,712
Accounts payable	16.5	27.1	41.4	36.9	28.1	28.7	49.5	80.3	70.2	87.2
Accrued liabilities	179	168	322	291	312	322	236	270	312	349
Deferred revenue	235	205	246	333	333	334	465	470	486	492
Short-term debt	126	37.9	87.5	76.3	53.9	47.4	55.7	51.5	20	25
Total current liabilities	561	444	1,922	2,776	2,283	3,851	2,191	3,772	4,354	5,111
Long-term debt	2,375	2,007	8,169	7,078	6,389	5,902	7,024	6,669	6,990	7,408
Lease liabilities				349	324	268	237	199	175	213
Other non-current liabilities	59.2	119	236	334	288	254	226	249	191	190
Total liabilities	3,448	2,853	11,528	11,625	10,207	11,110	10,550	11,705	12,436	13,770
Total debt	2,501	2,045	8,256	7,154	6,442	5,949	7,080	6,720	7,010	7,433
Paid-in capital	1,921	2,018	4,091	4,267	4,544	4,896	5,112	5,371	5,902	6,507
Retained earnings	492	767	847	1,178	1,667	2,293	2,740	3,126	3,642	4,179
Treasury stock	-18	-18	-18	-78.3	-296	-784	-1,260	-1,734	-2,470	-3,508
Other comprehensive income	-139	-82.7	-343	-253	-201	-242	-550	-426	-541	-294
Shareholders' equity	2,259	2,686	4,580	5,116	5,717	6,165	6,044	6,340	6,535	6,888
Minority interests					0	57.8	56.6	58.1	74.2	54.2
Total equity	2,259	2,686	4,580	5,116	5,717	6,223	6,101	6,398	6,609	6,942
Total liabilities and equity	5,707	5,540	16,108	16,741	15,924	17,333	16,653	18,103	19,045	20,712
Shares outstanding	203	207	251	255	258	256	251	247	245	241

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	131	329	103	439	625	801	649	609	762	799
Depreciation and amortization	229	237	519	775	725	667	672	670	680	704
Stock-based compensation	50.5	41.5	96.9	72.4	87.8	114	125	160	203	258
Deferred income tax	-47.8	-152	-106	-87.1	-155	-88	-77	-82.9	-115	-17.4
Change in receivables	-10.9	-1.8	50.4	9.9	24.3	-72.2	-38.1	-23.1	-119	-46
Change in payables	-1.3	13.8	-91	-0.7	-13.1	0.6	7.6	33	-10.7	14.1
Cash from operations	418	472	640	1,328	1,185	1,429	1,134	1,215	1,389	1,745
Capital expenditures	-27.9	-35.5	-33.6	-63	-34.8	-51.3	-63.4	-56.6	-61.4	-80.8
Acquisitions	-458	-17.4	-7,067	-94.1	-116	7.3	-1,636	-34.1	-647	-1,052
Purchases of investments	-1		-16.4	-0.3	-60.9	-20.1	-10	-0.6	-0.1	-2.5
Sales and maturities of investments			45.1	65.1	60.3	50.9	9.5	8	6.9	0.8
Cash from investing	-496	-63.3	-7,103	-141	-211	-148	-1,758	-268	-856	-1,308
Debt issued			8,744	2,241	286	370	1,727	375	5,545	1,187
Debt repaid	-384	-513	-3,141	-3,365	-1,024	-890	-600	-750	-5,255	-765
Stock issued	39.2	60.2	1,399	126	198	198	91.8	115	355	426
Share buybacks	-0.02			-60.3	-228	-488	-476	-472	-738	-1,036
Dividends paid	-50.1	-54.4	-70.9	-108	-136	-174	-203	-221	-245	-254
Cash from financing	-236	-468	7,517	-513	-1,428	557	-1,185	713	-152	-244
Exchange rate effect	-3.63	4.41
Net change in cash	-317	-55	1,049	676	-452	1,834	-1,834	1,661	372	203
Free cash flow	391	436	607	1,265	1,150	1,378	1,071	1,159	1,327	1,664
Interest paid	127	103	250	354	236	193	298	462	452	428
Income taxes paid	8.8	67.6	143	223	227	310	281	349	286	219

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $78.61 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	48.1%	Gross profit / revenue.
Operating margin	23.6%	Operating income / revenue.
EBITDA margin	29.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	16.6%	Pre-tax income / revenue.
Net margin	13.2%	Net income / revenue.
FCF margin	26.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	27.7%	Cash from operations / revenue.
Effective tax rate	20.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	13.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.2%	Net income / average total assets.
Return on invested capital (ROIC)	8.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	7.9%	Research and development expense / revenue.
Stock-based pay / revenue	4.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.0%	Capital expenditures / revenue.
D&A / revenue	6.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	6.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	6.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	7.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	7.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	5.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	5.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	4.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	4.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	7.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	5.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	5.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	8.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	6.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	25.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	15.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	8.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	25.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	15.8%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	7.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	6.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	9.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	14.4%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	5.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	8.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.06x	Current assets / current liabilities.
Quick ratio	0.27x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.14x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	36.8%	Total debt / total assets.
Liabilities / assets	67.4%	Total liabilities / total assets.
Net debt	$7.14B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.67x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	3.55x	Operating income / interest expense.
Working capital	$345.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	48.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$3.29B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.32x	Revenue / average total assets.
Fixed asset turnover	24.7x	Revenue / average property, plant and equipment.
Receivables turnover	6.41x	Revenue / average receivables.
Days sales outstanding	57 days	365 x average receivables / revenue.
Days payables	7 days	365 x average accounts payable / cost of revenue.
FCF conversion	202.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	3.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.57	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$27.13	Revenue / diluted weighted shares.
FCF per share	$7.24	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.50	Cash from operations / diluted weighted shares.
Book value per share	$28.31	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$14.02	Tangible book value / shares outstanding.
Cash per share	$1.85	(Cash + short-term investments) / shares outstanding.
Payout ratio	30.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	14.9%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	66.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$18.45B	Share price x shares outstanding.
Enterprise value	$25.59B	Market cap + total debt - cash - short-term investments.
P/E	21.3x	Market cap / net income. Only when net income is positive.
P/S	2.81x	Market cap / revenue.
P/B	2.78x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	10.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	10.2x	Market cap / cash from operations, when positive.
EV/Sales	3.90x	Enterprise value / revenue.
EV/EBIT	16.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	14.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.5%	Free cash flow / market cap.
Earnings yield	4.7%	Net income / market cap (the inverse of P/E).
Dividend yield	1.4%	Dividends paid over the period / market cap.
Shareholder yield	7.7%	(Dividends paid + share buybacks) / market cap.
PEG	2.57x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was SS&C Technologies Holdings Inc's revenue in fiscal 2025?

SS&C Technologies Holdings Inc reported revenue of $6.27B for fiscal 2025, 6.6% higher than the year before.

Was SS&C Technologies Holdings Inc profitable in fiscal 2025?

Yes. Net income was $796.9M, a net margin of 12.7%.

How much free cash flow did SS&C Technologies Holdings Inc generate in fiscal 2025?

Cash from operations of $1.74B minus capital expenditures of $80.8M left free cash flow of $1.66B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SS&C Technologies Holdings Inc